{"id":"NCT01918332","sponsor":"LG Life Sciences","briefTitle":"Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia","officialTitle":"A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase Ⅲ Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-04","primaryCompletion":"2013-03","completion":"2013-03","firstPosted":"2013-08-07","resultsPosted":"2014-12-15","lastUpdate":"2014-12-15"},"enrollment":168,"design":{"allocation":"RANDOMIZED","model":"FACTORIAL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension,","Hyperlipidemia"],"interventions":[{"type":"DRUG","name":"Valsartan 160mg","otherNames":["Diovan"]},{"type":"DRUG","name":"Rosuvastatin 20mg","otherNames":["Crestor"]},{"type":"DRUG","name":"Valsartan 160mg placebo","otherNames":[]},{"type":"DRUG","name":"Rosuvastatin 20mg placebo","otherNames":[]}],"arms":[{"label":"Valsartan 160mg, Rosuvastatin 20mg","type":"EXPERIMENTAL"},{"label":"Valsartan 160mg, Rosuvastatin 20mg placebo","type":"ACTIVE_COMPARATOR"},{"label":"Valsartan 160mg placebo, Rosuvastatin 20mg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study aims to evaluate the efficacy and safety of the coadministration of valsartan (Diovan®) 160mg and rosuvastatin (Crestor®) 20mg in comparison to each component administered alone in patients with hypertension and hyperlipidemia.","primaryOutcome":{"measure":"sitDBP Changes at Week 8 From Baseline","timeFrame":"8 weeks","effectByArm":[{"arm":"V160+R20 & V160","deltaMin":-9.24,"sd":null},{"arm":"R20 & Placebo","deltaMin":-2.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":43},"commonTop":["headache","dyspepsia","alanine aminotransferase increased","dizziness","nausea"]}}